Dose Ranging Effects of Three Low-doses of Naturlose (Tagatose) on Glycemic Control and Safety of Naturlose (Tagatose) Over Six Months in Subjects With Mild Type 2 Diabetes Mellitus Under Control With Diet and Exercise.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2016
At a glance
- Drugs D-tagatose (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 21 Jan 2011 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
- 10 Dec 2010 Results were reported in a Spherix media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History